Skip to main content
. 2020 Jan 29;15:5. doi: 10.1186/s13027-020-0275-0

Table 3.

Description of study variables in patients with co-occurrence of HCC and CE (HCC + CE) as well as control patients with HCC (HCC)

Condition Variable HCC + CE (n = 13) No. (%) HCC (n = 65) No. (%) aP
Gender Male 8 (61.54) 40 (61.54) 1.00
Female 5 (38.46) 25 (61.54)
Virus infection No 6 (46.15) 31 (47.69) 0.7769
Hepatitis A, B and C virus Yes 7 (53.85) 34 (52.31)
Alcohol consumption No 13 (100) 63 (96.92) 0.0810
*Yes 0 (0) 2 (3.08)
Aflatoxin No 13 (100) 65 (100) 1.00
Yes 0 (0) 0 (0)
NASH No 13 (100) 63 (96.92) 0.0810
Yes 0 (0) 2 (3.08)
Cirrhosis No 3 (23.08) 17 (26.15) 0.6218
Yes 10 (76.92) 48 (73.85)
Hemochromatosis No 13 (100) 65 (100) 1.00
Yes 0 (0) 0 (0)
Family cancer history No 12 (92.31) 59 (90.77) 0.7998
Yes 1 (7.69) 15 (9.23)

* ≥  1 glasses weekly for the past 6 months; NASH nonalcoholic steatohepatitis; aP-Value from χ2 test or Fisher‘s exact test where number is less than 5